Autotransplantation of the Adipose Tissue-Derived Mesenchymal Stromal Cells in Therapy of Venous Stasis Ulcers
Autor: | Leszek Masłowski, Maria Paprocka, Aleksandra Bielawska-Pohl, Wojciech Witkiewicz, Anna Czarnecka, Danuta Duś, Ryszard Grendziak, Agnieszka Czyżewska-Buczyńska |
---|---|
Rok vydání: | 2020 |
Předmět: |
Male
Pathology medicine.medical_specialty Stromal cell medicine.medical_treatment Immunology CD34 Adipose tissue Pilot Projects Mesenchymal Stem Cell Transplantation Transplantation Autologous Varicose Ulcer 03 medical and health sciences 0302 clinical medicine medicine Humans Immunology and Allergy CD90 Aged Wound Healing business.industry Mesenchymal stem cell Mesenchymal Stem Cells General Medicine Middle Aged Autotransplantation Transplantation Phenotype Treatment Outcome Adipose Tissue Chronic Disease Female Wound healing business Biomarkers 030215 immunology |
Zdroj: | Archivum Immunologiae et Therapiae Experimentalis. 68 |
ISSN: | 1661-4917 0004-069X |
DOI: | 10.1007/s00005-020-00571-9 |
Popis: | Adipose tissue is a reliable source of mesenchymal stromal cells (MSC) for use in regenerative medicine. The aim of this pilot study was to describe the method, and assess the safety and the potential efficacy of transplantation of autologous adipose tissue-derived MSC for the treatment of chronic venous stasis ulcers. Study group consisted of 11 patients (mean age: 66.6 ± 9.5 years) with chronic venous stasis ulcers. Adipose tissue was harvested by tumescent-aspiration method. Stromal cells were separated using a dedicated closed system in a real-time bedside manner. The phenotype of cells was determined immediately after separation. Cell concentrate was implanted subcutaneously around the wound and the wound bed. All ulcers were assessed planimetrically before autotransplantation and every two weeks during the six-month follow-up. During the study all patients received standard local and general treatment. The preparation contained an average of 5.6 × 106 ± 4 × 106 cells per milliliter. The phenotype of 65–82% of transplanted cells expressed MSC markers: CD73+ CD90+ and CD34+. An improvement was observed in 75% of ulcers. The data showed highly significant negative correlation (p |
Databáze: | OpenAIRE |
Externí odkaz: |